Tiffany Olson
President, Nuclear & Precision Health Solutions
Tiffany Olson is the president of Nuclear & Precision Health Solutions at Cardinal Health. Nuclear & Precision Health Solutions develops, manufactures, compounds, dispenses and delivers 12 million time-critical patient-specific doses annually to thousands of customers via a network of nuclear pharmacies and manufacturing sites that span the United States.
Prior to Cardinal Health, Tiffany was President of NaviMed, a company focused on personalizing medicine through innovative diagnostics. She also worked for Eli Lilly and Company, where she was tasked with leading the effort to formulate the strategy to create and commercialize diagnostics and companion diagnostics.
Tiffany worked for Roche Diagnostics for many years, where she attained the position of President and CEO of Roche Diagnostics Corporation. Prior to this appointment Tiffany was the Global Head of Market Development located in Basel, Switzerland. Other positions she held with the company included Vice President of Roche Molecular Diagnostics and Vice President of Corporate Accounts. She also spent a number of years in leading positions with other healthcare organizations.
Tiffany was the first woman to receive the Life Science Alley Luminary Award, recognizing her “rich career in medical diagnostics…exceptional reputation as a leader and her vision to drive both innovation and value for personalized medicine.” In 2013, she received the “Woman of Wellness Award” for her extraordinary contributions in her volunteer work in oncology. Most recently, she was recognized as one of the “10 Best Women Leaders of 2020” by Industry Era. She currently serves as an ambassador with the American Cancer Society through the ResearcHERS: Women Fighting Cancer Campaign, which helps fund women-led cancer research and bolster the careers of women in the field. She has written several articles on personalized medicine, molecular diagnostics and business strategy.
Tiffany has a bachelor’s degree in business from the University of Minnesota and a master’s degree from St. Thomas University in Minnesota. She has held several board positions and currently serves as a Board Member for Asuragen.
